The impact of newly approved drugs on clinical and operational strategies for multiple myeloma clinical trials.

Bhavani Krishnan,Bernadette Collins,Michael Jeffrey Cho,Tanya Partridge,Durga Vighnay,Marie Given,Sari H. Enschede,Katarzyna Bochenska,Jeff Paul Hodge

The impact of newly approved drugs on clinical and operational strategies for multiple myeloma clinical trials.

2019

Bhavani Krishnan
Bernadette Collins
Michael Jeffrey Cho
Tanya Partridge
Durga Vighnay
Marie Given
Sari H. Enschede
Katarzyna Bochenska
Jeff Paul Hodge

e19511Background: The global burden of multiple myeloma (MM) has increased steadily in last 3 decades. The IARC reports there were ~160,000 new cases worldwide in 2018. There has been an increase i...

Keywords:

Physical therapy
Clinical trial
Intensive care medicine
Medicine
Multiple myeloma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations